HEMOGENYX PHARMPLC (Germany) Price on December 24, 2024
| 5HU Stock | EUR 4.04 0.25 6.60% |
If you're considering investing in HEMOGENYX Stock, it is important to understand the factors that can impact its price. As of today, the current price of HEMOGENYX PHARMPLC stands at 4.04, as last reported on the 25th of December, with the highest price reaching 4.04 and the lowest price hitting 3.68 during the day. HEMOGENYX PHARMPLC is out of control given 3 months investment horizon. HEMOGENYX PHARMPLC holds Efficiency (Sharpe) Ratio of 0.12, which attests that the entity had a 0.12% return per unit of risk over the last 3 months. We were able to interpolate twenty-nine different technical indicators, which can help you to evaluate if expected returns of 15.79% are justified by taking the suggested risk. Use HEMOGENYX PHARMPLC LS 01 Risk Adjusted Performance of 0.109, semi deviation of 17.3, and Market Risk Adjusted Performance of 0.8846 to evaluate company specific risk that cannot be diversified away.
HEMOGENYX Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
HEMOGENYX |
Sharpe Ratio = 0.1228
| Best Portfolio | Best Equity | 5HU | ||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 128.6 actual daily | 96 96% of assets are less volatile |
Expected Return
| 5.01 actual daily | 96 96% of assets have lower returns |
Risk-Adjusted Return
| 0.12 actual daily | 9 91% of assets perform better |
Based on monthly moving average HEMOGENYX PHARMPLC is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of HEMOGENYX PHARMPLC by adding it to a well-diversified portfolio.
HEMOGENYX PHARMPLC Valuation on December 24, 2024
It is possible to determine the worth of HEMOGENYX PHARMPLC on a given historical date. On December 24, 2024 HEMOGENYX was worth 3.68 at the beginning of the trading date compared to the closed value of 4.04. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of HEMOGENYX PHARMPLC stock. Still, in general, we apply an absolute valuation method to find HEMOGENYX PHARMPLC's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of HEMOGENYX PHARMPLC where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against HEMOGENYX PHARMPLC's related companies.
| Open | High | Low | Close | Volume | |
| 3.68 | 4.04 | 3.68 | 4.04 | 1.00 | |
12/25/2024 | 3.68 | 4.04 | 3.68 | 4.04 | 0.00 |
| Backtest HEMOGENYX PHARMPLC | | | HEMOGENYX PHARMPLC History | | | HEMOGENYX PHARMPLC Valuation | Previous |
HEMOGENYX PHARMPLC Trading Date Momentum on December 24, 2024
| On December 25 2024 HEMOGENYX PHARMPLC LS 01 was traded for 4.04 at the closing time. The highest daily price throughout the period was 4.04 and the lowest price was 3.68 . There was no trading activity during the period 0.0. Lack of trading volume on 12/25/2024 did not cause price change. The trading delta at closing time to current closing price is 8.91% . |
HEMOGENYX PHARMPLC Fundamentals Correlations and Trends
By evaluating HEMOGENYX PHARMPLC's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among HEMOGENYX PHARMPLC's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. HEMOGENYX financial account trend analysis is a perfect complement when working with valuation or volatility modules.About HEMOGENYX PHARMPLC Stock history
HEMOGENYX PHARMPLC investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for HEMOGENYX is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in HEMOGENYX PHARMPLC will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing HEMOGENYX PHARMPLC stock prices may prove useful in developing a viable investing in HEMOGENYX PHARMPLC
Hemogenyx Pharmaceuticals Plc, a preclinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies and treatments for blood diseases. The company was incorporated in 2013 and is headquartered in London, the United Kingdom. HEMOGENYX PHARM is traded on Frankfurt Stock Exchange in Germany.
HEMOGENYX PHARMPLC Stock Technical Analysis
HEMOGENYX PHARMPLC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
HEMOGENYX PHARMPLC Period Price Range
Low | December 25, 2024
| High |
0.00 | 0.00 |
HEMOGENYX PHARMPLC LS 01 cannot be verified against its exchange. Please verify the symbol is currently traded on Frankfurt Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
HEMOGENYX PHARMPLC December 25, 2024 Market Strength
Market strength indicators help investors to evaluate how HEMOGENYX PHARMPLC stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading HEMOGENYX PHARMPLC shares will generate the highest return on investment. By undertsting and applying HEMOGENYX PHARMPLC stock market strength indicators, traders can identify HEMOGENYX PHARMPLC LS 01 entry and exit signals to maximize returns
HEMOGENYX PHARMPLC Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for HEMOGENYX PHARMPLC's price direction in advance. Along with the technical and fundamental analysis of HEMOGENYX Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of HEMOGENYX to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.109 | |||
| Jensen Alpha | 32.34 | |||
| Total Risk Alpha | 21.86 | |||
| Sortino Ratio | 1.44 | |||
| Treynor Ratio | 0.8746 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for HEMOGENYX Stock analysis
When running HEMOGENYX PHARMPLC's price analysis, check to measure HEMOGENYX PHARMPLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HEMOGENYX PHARMPLC is operating at the current time. Most of HEMOGENYX PHARMPLC's value examination focuses on studying past and present price action to predict the probability of HEMOGENYX PHARMPLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HEMOGENYX PHARMPLC's price. Additionally, you may evaluate how the addition of HEMOGENYX PHARMPLC to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |